saffron

Botanicalexperimental

Saffron is a spice derived from the flower of Crocus sativus, commonly known as the "saffron crocus". Crocin is a water-soluble carotenoid pigment of saffron,that has been used as a spice for flavoring and coloring food preparations, and in Chinese traditional medicine as an anodyne or tranquilizer. Saffron is now used worldwide in folk medicine and is reputed to be useful in treating various human disorders such as heart and blood disorders. Stroke and heart attack are involved in reputed folkloric uses of saffron. Saffron is orally administrated as a decoction. Saffron extract exerts a protective effect on renal ischemia reperfusion induced oxidative damage in rats. Crocin suppresses tumor necrosis factor (TNF) alpha-induced apoptosis of pheochromocytoma (PC12) cells by modulating mRNA expressions of Bcl-2 family proteins, which trigger downstream signals culminating in caspase-3 activation followed by cell death. Depriving cultured PC12 cells of serum/glucose causes a rapid increase in cellular ceramide levels, followed by an increase in the risk of cell death. The accumulation of ceramide was found to depend on the activation of neutral sphingomyelinase (nSMase). Crocin prevented the activation of nSMase by enhancing the transcription of gamma-glutamylcysteinyl synthase, which contributes to a stable glutathione supply that blocks the activity of nSMase. — NCATS

Clinical trial activity

14 trials · 17 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started May 31, 2012 (NCT01590485)

Timeline

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06240364N/AOct 10, 2024Pharmactive Biotech Products S.L., University Alicante
NCT06235021N/AJan 1, 2024British University In Egypt
NCT05715099Phase 4Mar 30, 2023Minia University
NCT05690126N/ADec 8, 2022Government of France
NCT05211063N/AOct 21, 2022Pharmactive Biotech Products S.L., University Alicante
NCT05696665N/AJul 5, 2022Aga Khan University, Jinnah Postgraduate Medical Centre, Liaquat University of Medical & Health Sciences
NCT06138470N/AMay 30, 2022Comercial Quimica Masso, S.A, Université catholique de Louvain
NCT05315986N/AApr 29, 2022University of East Anglia
NCT05117749Phase 2Feb 28, 2022Shiraz University
NCT05572749N/AMay 1, 2021Aristotle University of Thessaloniki
NCT04749576N/ADec 15, 2020Howard University
NCT04750681N/AAug 12, 2019Comercial Quimica Masso, S.A, Université catholique de Louvain
NCT03372109N/ANov 14, 2017LIfe Extension, Supplement Formulators, Inc.
NCT01590485N/AMay 31, 2012Zahedan University of Medical Sciences
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (17)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Comercial Quimica Masso, S.AFor profit2212019
Pharmactive Biotech Products S.L.For profit2012022
Université catholique de LouvainAcademic/Hospital2012019
University AlicanteAcademic/Hospital2212022
Aga Khan UniversityAcademic/Hospital1012022
Aristotle University of ThessalonikiAcademic/Hospital1112021
British University In EgyptAcademic/Hospital1112024
Government of FranceGovernment1112022
Howard UniversityAcademic/Hospital1112020
Jinnah Postgraduate Medical CentreAcademic/Hospital1112022
Liaquat University of Medical & Health SciencesAcademic/Hospital1012022
LIfe ExtensionAcademic/Hospital1012017
Minia UniversityAcademic/Hospital1112023
Shiraz UniversityAcademic/Hospital1112022
Supplement Formulators, Inc.For profit1112017
University of East AngliaAcademic/Hospital1112022
Zahedan University of Medical SciencesAcademic/Hospital1112012
17 organizations
Page 1 / 1